Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0VHVOA
ADC Name
TUB-030
Synonyms
TUB 030; TUB-030; TUB030
   Click to Show/Hide
Organization
Tubulis GmbH
Drug Status
Phase 1/2
Indication
In total 5 Indication(s)
Breast cancer
Phase 2
Clinical Trial
Colorectal cancer
Phase 2
Clinical Trial
Head and neck cancer
Phase 2
Clinical Trial
Lung cancer
Phase 2
Clinical Trial
Solid tumor
Phase 2
Clinical Trial
Drug-to-Antibody Ratio
8
Antibody Name
Undisclosed
Antigen Name
Trophoblast glycoprotein (TPBG)
  Antigen Info 
Payload Name
Exatecan
  Payload Info 
Therapeutic Target
DNA topoisomerase 1 (TOP1)
  Target Info 
Conjugate Type
Undisclosed
Combination Type
tubutecan